Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
P 1 (1)

Trial Status

Not Yet Recruiting2
Unknown1

Clinical Trials (3)

Showing 3 of 3 trials
NCT07301346Not ApplicableNot Yet RecruitingPrimary

EASEE® System Pivotal Study for the United States of America

NCT07249034Not ApplicableNot Yet Recruiting

Impact of Epilepsy on the Brainstem Adenosine Pathway and Its Relation With Arousal and Respiratory Reactivity

NCT05198882Phase 1UnknownPrimary

Clinical Evaluation of Interstitial Laser Thermal Therapy Under Continuous MRI Monitoring as a Minimally Invasive Treatment of Patients With Medically Unbalanced Partial Epilepsy

Showing all 3 trials

Research Network

Activity Timeline